SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is seeing high volatility as investors weigh strong earnings and long-term AI-driven revenue targets against concerns over massive pending share unlocks from early insiders. The community remains deeply divided, with bulls pointing to the company's long-term growth potential and institutional backing, while bears anticipate downward pressure from the significant expansion of the public float.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing heightened selling pressure and intense community debate as investors weigh the impact of rising competition from prediction markets and anticipation surrounding upcoming earnings. Bullish voices are pointing to strong user engagement and seasonal tailwinds, while bearish sentiment remains driven by concerns over market share erosion and the stock's persistent inability to gain momentum.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively pivot back to mega-cap hyperscalers, fueled by stronger-than-expected cloud growth and the market's evolving view that massive AI infrastructure spending is a long-term investment rather than an expense. The community is actively discussing the stock's resilience after testing key technical support levels, with many viewing the recent earnings-driven volatility as an opportunity for institutional accumulation rather than a fundamental change in growth trajectory.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is seeing heightened volatility as investors debate the sustainability of its aggressive AI infrastructure spending, despite strong cloud growth figures that exceeded expectations. The community remains sharply divided, with bulls pointing to the company's long-term dominance and undervalued valuation, while bears express concern over the impact of rising capital expenditures on free cash flow.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is experiencing significant downward pressure following reports that Waymo is exploring an exit from its robotaxi partnership, fueling concerns about long-term competition in the autonomous space. Despite this sentiment-driven volatility, the community remains divided between those calling for a structural sell-off due to management concerns and long-term investors highlighting the stock's strong cash flow and potential discount at current levels.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is seeing increased market attention and optimism following the appointment of a new CEO, Alisa Bowen, and her strategic shift toward deeper integration with Disneys streaming ecosystem. Community discussion is focused on the potential for a short squeeze, the impact of the Hulu + Live TV merger on future profitability, and skepticism regarding the company's long-term competitive position.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is currently in the spotlight as investors react to a significant earnings beat and strong growth outlook, which has fueled a sharp post-earnings rally. The community is actively debating whether this momentum marks a sustainable breakout driven by AI-powered commerce or if the stock remains susceptible to volatility and valuation concerns given the rapid nature of its recent price swings.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending due to a Q2 earnings beat that exceeded revenue and profit expectations, signaling potential improvements in its ad business and financial foundation. Investors are actively discussing the stock's turnaround prospects, the growth of Snapchat+, and the strategic importance of its AI/AR smartglasses amid debate over management's long-term vision.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in anticipation of an FDA decision on its drug candidate, with intense community debate surrounding the significance of a recent 10-3 advisory committee vote versus the company's prior regulatory hurdles. Investors are closely monitoring for potential news, with many speculating on whether an imminent announcement will trigger a massive short squeeze or lead to significant dilution and downside.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine is trending as shares rally on the back of a strong fiscal first quarter earnings report featuring double-digit revenue growth and raised full-year guidance. The community is actively debating whether this represents a long-term turnaround and re-rating for the ad-tech stock or a potential peak, with discussions heavily focused on technical breakout levels and the impact of the company's expanding AI-driven platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curis Doses First Five Patients in TakeAim CLL Study

Curis Doses First Five Patients in TakeAim CLL Study Curis Doses First Five Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 30, 2026 LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...

Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.read more...

Curis Strengthens Oncology Pipeline Outlook With Strong TakeAim Lymphoma Response Rates

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for the TakeAim CLL study.read more...

Curis Announces Positive Emavusertib Update

Curis Announces Positive Emavusertib Update Curis Announces Positive Emavusertib Update PR Newswire LEXINGTON, Mass., July 22, 2026 Updated Clinical Data in PCNSLIncreased Guidance on Year-End Data in CLLCompany to Host Webcast at 8:30 a.m. ETLEXINGTON, Mass., July 22, 2026 /PRNewswire/ -- Curis...

Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, Eshallgo up 20.3%, Curis up 10.9%, Sky Quarry up 10.6%, Accuray up 9.5%, Bitzero up 5.5%. Losers: Global Mofy down 25.3%, Jiuzi down 22.1%, Julong down 21.4%, Haoxi down 20.4%, Sadot down 20.4%.read...

Curis Consents First Six Patients in TakeAim CLL Study

Curis Consents First Six Patients in TakeAim CLL Study Curis Consents First Six Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 6, 2026 LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...

Why Did Curis (CRIS) Stock Soar After Hours?

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stock split will take effect on Thursday.read more...

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million.
Humacyte (NASDAQ:HUMA) shares moved upwards by 5.45% to $0.71.read more...

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of...

Curis Reports Q1 2026 Results: Full Earnings Call Transcript

$CRIS Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$1.25
• Curis believes its $15M cash as of March 31, 2026, plus anticipated $20.2M from warrant exercise, should fund planned operations into the second half of 2027.

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Curis Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.51
Prev Close	$4.72
Open	$4.84
Dividend Yield	0.00%
50-Day Moving Average	$7.09
Beta	1.10
Avg. Volume	92,230.92
PE Ratio	-0.20

52-Week High	$39.00
52-Week Low	$3.61
Market Capitalization	$9.2M
EPS (Annual)	-$11.52
Price to Book	0.74
Revenue Per Employee	$393,458.33

Feed

News

Sentiment

Earnings

Fundamentals

Info